Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VCEL
VCEL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VCEL News
Soleus Capital Increases Stake in Vericel
1d ago
NASDAQ.COM
Soleus Capital Increases Stake in Vericel Significantly
1d ago
Fool
Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine
May 22 2026
Globenewswire
Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine
May 22 2026
Newsfilter
Vericel Corporation Reports Record Q1 2026 Earnings with Increased Guidance
May 08 2026
seekingalpha
Vericel Q1 Earnings Beat Expectations with Strong Revenue Growth
May 07 2026
seekingalpha
Vericel Scheduled to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Cell Therapy Market Set to Nearly Double by 2035
Apr 06 2026
Newsfilter
Vericel Secures $197M Contract with U.S. BARDA
Apr 02 2026
seekingalpha
Vericel Secures $197 Million BARDA Contract
Apr 02 2026
Newsfilter
MediWound Reports $197 Million BARDA Contract Award to Vericel for NexoBrid
Apr 02 2026
Newsfilter
Vericel Receives Approval for MACI Commercial Production
Mar 04 2026
Newsfilter
Vericel Corporation to Present at Upcoming Investor Conferences
Mar 03 2026
Newsfilter
Vericel Corporation Reports Strong Q4 2025 Earnings with Record Revenue Growth
Feb 26 2026
seekingalpha
Vericel Reports Significant Earnings Growth in Q4
Feb 26 2026
NASDAQ.COM
Vericel Q4 Earnings Exceed Expectations with Strong Revenue Growth
Feb 26 2026
seekingalpha
Show More News